ORCHPHARMAUpdated 1 Sept 2026, 1:38

Orchid Pharma Limited

ORCHPHARMAUpdated 1 Sept 2026, 1:38

Market Cap

₹5,829Cr.

Current Price

₹971

High / Low

₹1,133/471

Stock P/E

121

ROE3.11%

ROCE3.33%

Book Value₹270

Face Value₹10.0

Dividend Yield0.00%

About

Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	61	156	101	82	88	50	107	105	116	84	96	78
Inventory Days	113	183	196	204	219	257	240	201	217	199	219	111
Days Payable	138	307	410	361	354	110	109	140	130	135	114	69
Cash Conversion Cycle	36	32	-113	-74	-47	197	237	165	204	148	200	120
Working Capital Days	-32	-127	-504	-901	-1,159	197	330	121	79	140	152	115
ROCE %	1%	2%	-3%	-3%	-5%	-4%	-4%	-2%	5%	9%	9%	3%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 1:38

ORCHID PHARMA LIMITED (ORCHPHARMA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding